Live Breaking News & Updates on Prnewswire Nanoform Finland Plc

Stay updated with breaking news from Prnewswire nanoform finland plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nanoform technology delivers successful results for Herantis CDNF drug candidate

Nanoform technology delivers successful results for Herantis CDNF drug candidate
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Eteläuomen Läi , Christian Jones , Craig Cook , Herantis Pharma , Prnewswire Nanoform Finland Plc , Danske Bank , Finnish Financial Supervisory Authority , Herantis Pharma Plc , Finland Branch , Finland Plc , Cerebral Dopamine Neurotrophic Factor , Nanoform Proof , Chief Commercial Officer , Chief Commercial , Nasdaq First North Growth Market , Certified Adviser , Nasdaq First North Growth Market Finland ,

Invitation to presentation of Nanoform's Q1/2021 report on May 27, 2021


Invitation to presentation of Nanoform s Q1/2021 report on May 27, 2021
HELSINKI, May 12, 2021 /PRNewswire/ Nanoform Finland Plc (
Nanoform ), an innovative nanoparticle medicine enabling company, will publish its Q1/2021 report on May 27, 2021, at 8.10 a.m. Finnish time / 7.10 a.m. Swedish time.
The company will hold a conference call and an online presentation on the same day at 3.00 p.m. Finnish time / 2.00 p.m. Swedish time. Nanoform will be represented by CEO Edward Hæggström, CFO Albert Hæggström and CBO Gonçalo Andrade. The presentation will be delivered in English.
The presentation will be broadcast live as a webcast available at: ....

Eteläuomen Läi , United Kingdom , Prnewswire Nanoform Finland Plc , Danske Bank , Finland Branch , Finland Plc , Nasdaq First North Growth Market , Certified Adviser , ஒன்றுபட்டது கிஂக்டம் , பின்லாந்து கிளை , பின்லாந்து ப்ல் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை ,